Pathway Genomics vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
CAP- and CLIA-accredited clinical genetic testing lab offering cancer risk, cardiac, pharmacogenomics, and wellness panels to physicians and patients; privately held, San Diego, founded 2008.
About
Pathway Genomics (also known as Pathway OME) is a privately held clinical genetic testing company founded in 2008 and headquartered in San Diego, California. The company operates a CAP-accredited and CLIA-certified clinical laboratory that provides physicians and patients with actionable, precision healthcare information derived from genetic analysis. Pathway's testing services cover cancer risk assessment, cardiac health, pharmacogenomics (drug response), inherited disease risk, nutrition and exercise response, and reproductive health — enabling personalized healthcare decisions grounded in genetic data.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.